Company / EPS (Basic)
Supernus Pharmaceuticals, Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.02
FY2025
5-year range
$0.02 / $2.41
FY2021-FY2025
Trend
-98.2%
vs FY2024
Sector context
#49 of 208
Health Care
What the data says
Supernus Pharmaceuticals, Inc.'s eps (basic) of $0.02 is higher than 76% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 10 years, ranging from $-0.26 in FY2016 to $2.41 in FY2022.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -60.7%. Top quartile in the Health Care sector.
Remained stable around $0.02 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -79.8%
- 5-Year CAGR
- -60.7%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 208This company $0.02 Sector average -$0.87
▼
+102.3% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 98.2% year-over-year.
- Ranks #49 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2022.
- Lowest eps (basic) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -98.2% |
| FY2024 | $1.13 | +5550.0% |
| FY2023 | $0.02 | -99.2% |
| FY2022 | $2.41 | +11.6% |
| FY2021 | $2.16 | +1.4% |
| FY2020 | $2.13 | +88.5% |
| FY2019 | $1.13 | -38.6% |
| FY2018 | $1.84 | +534.5% |
| FY2017 | $0.29 | +211.5% |
| FY2016 | -$0.26 | +91.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026